Howe & Rusling’s ChemoCentryx, Inc. CCXI Stock Holding History

Howe & Rusling’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-61	Closed	-$3K	–	1131
2022 Q3	$3K	Buy	61 +22	+56%	+$909	﹤0.01%	831
2022 Q2	$1K	Buy	39 +19	+95%	+$419	﹤0.01%	1037
2022 Q1	$1K	Sell	20 -6	-23%	-$169	﹤0.01%	988
2021 Q4	$1K	Buy	+26	New	+$913	﹤0.01%	976

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Howe & Rusling's CCXI Position: Q4 2022 in Review

Howe & Rusling sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 61 shares — an estimated $3K sold.

Howe & Rusling first reported a position in CCXI in Q4 2021 and held it in 4 quarters. The position peaked at $3K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Howe & Rusling reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Howe & Rusling sold 61 ChemoCentryx, Inc. shares in Q4 2022, an estimated $3K.
Howe & Rusling first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 4 quarters.
Howe & Rusling's ChemoCentryx, Inc. position peaked at $3K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.